UBS Group
ICUI icon

UBS Group’s ICU Medical ICUI Stock Holding History

UBS Group’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.7M Sell
114,138
-65,438
-36% -$9.41M ﹤0.01% 2921
2025
Q4 		$25.6M Sell
179,576
-206,979
-54% -$27.7M ﹤0.01% 2344
2025
Q3 		$46.4M Buy
386,555
+272,782
+240% +$34.6M 0.01% 1708
2025
Q2 		$15M Buy
113,773
+3,823
+3% +$518K ﹤0.01% 2678
2025
Q1 		$15.3M Buy
109,950
+24,053
+28% +$3.73M ﹤0.01% 2611
2024
Q4 		$13.3M Buy
85,897
+57,292
+200% +$9.69M ﹤0.01% 2744
2024
Q3 		$5.21M Buy
28,605
+16,410
+135% +$2.43M ﹤0.01% 3023
2024
Q2 		$1.45M Buy
12,195
+961
+9% +$101K ﹤0.01% 4071
2024
Q1 		$1.21M Buy
11,234
+3,102
+38% +$308K ﹤0.01% 4454
2023
Q4 		$811K Sell
8,132
-10,732
-57% -$1.05M ﹤0.01% 4677
2023
Q3 		$2.25M Buy
18,864
+13,341
+242% +$1.99M ﹤0.01% 3333
2023
Q2 		$984K Sell
5,523
-10,563
-66% -$1.94M ﹤0.01% 4258
2023
Q1 		$2.65M Sell
16,086
-2,178
-12% -$375K ﹤0.01% 3129
2022
Q4 		$2.88M Sell
18,264
-27,196
-60% -$4.14M ﹤0.01% 3018
2022
Q3 		$6.85M Sell
45,460
-19,797
-30% -$3.29M ﹤0.01% 2091
2022
Q2 		$10.7M Sell
65,257
-4,472
-6% -$861K ﹤0.01% 1765
2022
Q1 		$15.5M Sell
69,729
-6,280
-8% -$1.41M 0.01% 1626
2021
Q4 		$18M Buy
76,009
+15,552
+26% +$3.63M 0.01% 1657
2021
Q3 		$14.1M Buy
60,457
+45,569
+306% +$9.56M ﹤0.01% 1775
2021
Q2 		$3.06M Buy
14,888
+3,298
+28% +$678K ﹤0.01% 3164
2021
Q1 		$2.38M Sell
11,590
-1,671
-13% -$353K ﹤0.01% 3392
2020
Q4 		$2.84M Sell
13,261
-784
-6% -$152K ﹤0.01% 3040
2020
Q3 		$2.57M Buy
14,045
+7,340
+109% +$1.38M ﹤0.01% 2816
2020
Q2 		$1.24M Sell
6,705
-3,957
-37% -$786K ﹤0.01% 3325
2020
Q1 		$2.15M Sell
10,662
-16,169
-60% -$3.11M ﹤0.01% 2696
2019
Q4 		$5.02M Buy
26,831
+15,174
+130% +$2.61M ﹤0.01% 2601
2019
Q3 		$1.86M Sell
11,657
-1,882
-14% -$375K ﹤0.01% 3356
2019
Q2 		$3.41M Sell
13,539
-7,010
-34% -$1.62M ﹤0.01% 2657
2019
Q1 		$4.92M Buy
20,549
+1,316
+7% +$316K ﹤0.01% 2215
2018
Q4 		$4.42M Sell
19,233
-8,983
-32% -$2.21M ﹤0.01% 2265
2018
Q3 		$7.98M Buy
28,216
+4,762
+20% +$1.39M ﹤0.01% 1960
2018
Q2 		$6.89M Buy
23,454
+9,964
+74% +$2.72M ﹤0.01% 2060
2018
Q1 		$3.4M Sell
13,490
-11,615
-46% -$2.73M ﹤0.01% 2661
2017
Q4 		$5.42M Buy
25,105
+9,606
+62% +$1.94M ﹤0.01% 2272
2017
Q3 		$2.88M Buy
15,499
+1,689
+12% +$295K ﹤0.01% 2757
2017
Q2 		$2.38M Buy
13,810
+708
+5% +$114K ﹤0.01% 2851
2017
Q1 		$2M Sell
13,102
-1,462
-10% -$214K ﹤0.01% 2938
2016
Q4 		$2.15M Buy
14,564
+1,351
+10% +$196K ﹤0.01% 2862
2016
Q3 		$1.67M Buy
13,213
+677
+5% +$81.6K ﹤0.01% 3008
2016
Q2 		$1.41M Sell
12,536
-13
-0.1% -$1.35K ﹤0.01% 3077
2016
Q1 		$1.31M Sell
12,549
-579
-4% -$55.4K ﹤0.01% 3037
2015
Q4 		$1.48M Sell
13,128
-5,627
-30% -$622K ﹤0.01% 3086
2015
Q3 		$2.05M Buy
18,755
+2,689
+17% +$288K ﹤0.01% 2720
2015
Q2 		$1.54M Sell
16,066
-5,153
-24% -$482K ﹤0.01% 3231
2015
Q1 		$1.98M Buy
21,219
+8,532
+67% +$746K ﹤0.01% 2935
2014
Q4 		$1.04M Buy
+12,687
New +$973K ﹤0.01% 3540

Other funds holding ICUI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's ICUI Position: Q1 2026 in Review

UBS Group reduced its ICU Medical (ICUI) stake by 36% in Q1 2026, selling an estimated $9.41M and leaving 114,138 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2921.

UBS Group first reported a position in ICUI in Q4 2014 and has held it in 46 quarters since. The position peaked at $46.4M in Q3 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • UBS Group held 114,138 shares of ICU Medical worth $14.7M as of Q1 2026.
  • UBS Group sold 65,438 ICU Medical shares in Q1 2026, an estimated $9.41M.
  • ICU Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2921 holding.
  • UBS Group first reported a position in ICU Medical in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's ICU Medical position peaked at $46.4M in Q3 2025.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.